Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Italian Prostate Biopsies Group: 2016 Updated Guidelines Insights.

Andrea Fandella1, Vincenzo Scattoni2, Andrea Galosi3

  • 1Department of Urology, Giovanni XXIII Clinic, Monastier di Treviso, Treviso, Italy.

Anticancer Research
|February 10, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Focal Therapy for Prostate Cancer: A Treatment Option Reserved for the Ideal Candi-date?

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same author

Impact of prostate mpMRI quality on diagnostic accuracy in prostate cancer: a prospective study.

BJU international·2026
Same author

ProBIOPSY: A Multidisciplinary International Consensus on Standards for Prostate Biopsy.

European urology·2026
Same author

Focal Therapy for Localized Prostate Cancer: Maturing Evidence, Evolving Questions.

European urology·2026
Same author

Temporal Trends of Metastatic Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era in the United States.

The Prostate·2026
Same author

PSMA PET/CT-Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Updated Italian guidelines recommend initial prostate biopsies for elevated PSA, abnormal rectal exams, or suspicious MRI findings (PIRADS ≥4). Multiparametric MRI is advised for prior negative biopsies, with at least 12 cores plus targeted biopsies recommended.

Area of Science:

  • Urology
  • Pathology
  • Radiology

Background:

  • Prostate biopsies are crucial for diagnosing prostate cancer.
  • Guidelines require regular updates based on emerging evidence.

Purpose of the Study:

  • To summarize updated Italian Prostate Biopsies Group guidelines.
  • Incorporate recent literature evidence (2012-2015) into recommendations.

Main Methods:

  • Systematic review of English-language literature (2012-2015).
  • Expert panel (14 urology, pathology, radiology specialists).
  • Evidence grading using the GRADE framework.

Main Results:

  • Initial biopsy recommended for PSA >10 ng/ml, abnormal DRE, or PIRADS ≥4 on mpMRI.
Keywords:
MRI/TRUS fusion biopsyProstate cancermultiparametric MRIprostate biopsyreviewtransperineal prostate biopsytransrectal prostate biopsy

Related Experiment Videos

  • mpMRI strongly recommended for patients with prior negative biopsies.
  • Minimum 12 cores plus targeted biopsies; saturation biopsies are optional.
  • Gleason grade groups recommended alongside Gleason score.

    • Conclusions:

    • Updated guidelines aid physician and patient decision-making for prostate biopsies.
    • Emphasize the role of mpMRI in guiding biopsy decisions.